StockData
Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc. (VYGR) stock

VYGRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3053% below fair value
$1.61−0.06 (-3.59%)

Close on Nov 19, 2026Market cap $99.20MP/E –Yield –

Voyager Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Voyager Therapeutics

Voyager Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Voyager Therapeutics figures

See a number that looks wrong?